New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2014
08:47 EDTEPZMEpizyme price target raised to $52 from $37 at Wedbush
Wedbush increased its price target on Epizyme after the company released clinical data on its EPZ-5676 treatment that the firm views as positive. The firm reiterates an Outperform rating on the stock.
News For EPZM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 25, 2015
07:41 EDTEPZMEpizyme management to meet with Leerink
Subscribe for More Information
June 22, 2015
13:20 EDTEPZMOn The Fly: Top stock stories at midday
Subscribe for More Information
June 21, 2015
15:09 EDTEPZMEpizyme to hold a conference call
Subscribe for More Information
12:37 EDTEPZMEpizyme reports phase 1 tazemetostat results, plans phase 2 trial in Q2
Subscribe for More Information
June 17, 2015
07:17 EDTEPZMOncology Institute of Southern Switzerland to hold a conference
13th International Conference on Malignant Lymphoma: ICML 2015 is being held in Rome, Italy on June 17-20.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use